GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
Compounded semaglutide is a separate preparation made by an independent compounding pharmacy and hasn't undergone individual FDA review as a finished product
It is actually the more stable format, and reconstituting it yourself gives you control over the concentration
Therefore, be patient and stick to your diet plan because this medication may take weeks or months to show visible results
However, this mechanism could potentially increase the risk of pulmonary aspiration during anaesthesia
Any respondent who selected the clearly inferior profile was prompted to reconsider their decision, and was not allowed to progress without selecting the alternative (clearly superior) profile